Nathan Smith
Chief Executive / NeuroScientific Biopharmaceuticals
| Rank | Company | # | |
|---|---|---|---|
| 158th | - | NeuroScientific Biopharmaceuticals | $0 |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 162nd | Ore Resources | 147.37% | -28.7% |
| 163rd | St Barbara | 146.03% | -6.1% |
| 164th | NeuroScientific Biopharmaceuticals | 146.02% | -18.95% |
| 165th | Challenger Gold | 145.7% | -13.24% |
| 166th | Brazilian Rare Earths | 145.03% | 0% |
|
NEWS: Tagged in NeuroScientific readies stem cell supply boost for bowel disease trials | 17 Mar 2026 |
|
NEWS: Tagged in NeuroScientific Biopharmaceuticals soars on stem cell tech results | 13 Jan 2026 |
|
NEWS: Tagged in NeuroScientific widens chronic bowel disease stem cell therapy program | 11 Nov 2025 |
|
NEWS: Tagged in NeuroScientific locks in deal to scale-up stem cell production | 31 Jul 2025 |
|
NEWS: Tagged in Board moves July 29, 2025 | 29 Jul 2025 |
|
NEW ROLE: Chief Executive, NeuroScientific Biopharmaceuticals | 29 Jul 2025 |
Access to our data for Nathan Smith is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Nathan Smith is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.